Tetraphase Pharmaceuticals, Inc. (TTPH)

[Schnauzer1]

I'm not sure it's safe to assume anything with regard to these companies. I notice you do not mention the critical P3 for complicated interabdominal infection. That is the Pivital P3 for drug approval. ThecUTI is planned as a label extension trial. So much for projected timelines. The stock price is dead at the moment, largely due to a noticeable lack of activity. What biotech is not interested in communicating with the investment community? I suppose management could be in talks to sale the company. But I see that as a very long shot without a drug approving P3. Love the potential for the company, given its science. However, a lot of people have lost a lot of money because of this management team!